Research governance

Ethics


img_box.gif Science

img_box.gif Information

img_box.gif Health, safety and employment

img_box.gif Finance and intellectual property

img_box.gif Quality research culture

img_box.gif The responsibilities of those involved in research

img_box.gif Systems to deliver excellence in research

img_box.gif Monitoring, inspection and failures


Many of these areas will be covered in more detail in other chapters, but a preliminary overview is given here.


2.1 Ethics


This section of the framework is wide ranging and includes: independent ethical review; informed consent; valuing patient diversity; patient confidentiality; data protection; use of tissue or organs; the use of animals; and involvement of patients in research. The guiding principle is that the dignity, rights, safety and wellbeing of participants must be the primary consideration in any research study.


The requirements for the ethical review of research and participant consent are covered in Chapters 10 and 11.


2.1.1 Patient involvement in research


Patient involvement is an area of increasing importance and all new funding streams in the National Institute of Health Research ask for specific information about this. Patients can be successfully involved in all stages of the research process at a number of levels. Patient involvement is about more than just consulting patients but also seeking to collaborate or even encouraging patients to lead the development of the research question and methodology. This can be a challenging area for researchers since traditionally, patients and the public have had little or no input into what health research is carried out in the UK and particularly in the NHS. Advice is available from INVOLVE (www.invo.org.uk), and they provide examples of how patients can be successfully included into planning research.


2.2 Science


This part of the framework aims to ensure that all new research builds on the learning of previous work and will add something new and useful to the body of knowledge once complete. Thus, adequate review of the relevant literature is vital. Reviewing the literature is covered in Chapter 4.


The framework also makes clear that peer review by experts in the relevant fields is essential for all research to maintain scientific quality. The level of peer review should reflect the size of the study and its inherent risks. For example, a large and expensive clinical trial is likely to need review by an external panel of experts, whereas small unfunded projects could be reviewed by one or two people within the organisation. The arrangements will vary locally but there should be a system for peer review available.


2.3 Information


This section of the framework covers the use and dissemination of information arising from the research. The general principle is that all results should be made freely available subject to appropriate scientific review, and also be in a format understandable by the general public. The framework recognises that there may be issues around intellectual property or possible commercial development of the results of research and allows flexibility in the timing of the publication of results.


2.4 Health, safety and employment


The framework emphasises the importance of health and safety regulations. You must make sure you are following all health and safety guidelines in force in your organisation. We are all responsible for our own and others’ safety, and should act with this in mind. If you need to undertake any specific activity or procedure make sure you have been trained to do so in a safe manner, and understand the relevant health and safety regulations, such as regulations for working in a laboratory, taking blood, or operating equipment.


The Research Governance Framework says, ‘A researcher not employed by any NHS organisation who interacts with individuals in a way that has direct bearing on the quality of their care should hold an NHS honorary contract.’ (Section 3.10.3 of the Framework of England). It does not say every Trust must issue its own honorary contract, although in practice this is what tends to happen. This involves researchers going through an identical process several times in order to work in several different Trusts. This has been recognised as a waste of time and resources, so a researcher passport scheme has been piloted to avoid this duplication of information. Nevertheless, as yet there is no consistent approach, so you must check the local situation with your R & D or Human Resources Department. The NHS R & D forum may also provide helpful advice (www.rdforum.nhs.uk).


2.5 Finance and intellectual property


The framework underlines the need for compliance with the law and with the rules set out by HM Treasury for the use of public funds. It covers guidance on intellectual property rights, and it also covers the issue of indemnity against negligent and non-negligent harm to research participants, which is required to protect participants in trials. Research run within the NHS is covered by the standard complaints procedure, and the patient information sheet must include the indemnity procedure for the research. Sample wording is given in the National Ethics Research Service guidance (for website address see resources section).


If your research is being run in collaboration with an academic or commercial organisation there will be different indemnity arrangements. The National Research Ethics Service form asks for details of these, which you should be able to obtain from your local research services office or other management department.


2.6 Quality research culture


The framework recognises that although some parts of its guidance are clear and unequivocal, other parts require interpretation and judgement. In order to carry out high quality research that will meet all other requirements of the governance framework, strong research leadership and expert management is required. To engender an environment that will nurture excellence in research the following are listed as key principles:



img_box.gif Respect for participants’ dignity, rights, safety and wellbeing

img_box.gif Valuing diversity within society

img_box.gif Personal and scientific integrity, honesty and accountability

img_box.gif Clear and supportive management and leadership

img_box.gif A culture of openness

2.7 Your responsibilities


The framework also outlines the responsibilities of each person involved in research and Box 2.1 lists the main people and organisations involved. Each person or organisation listed has specific responsibilities described within the framework.



Box 2.1 Key roles and organisations involved in a health or social care research study.

Chief investigator


The person who takes overall responsibility for the design, conduct and reporting of a study if it is at one site; or if the study involves researchers at more than one site, the person who takes primary responsibility for the design, conduct and reporting of the study, whether or not that person is an investigator at any particular site.


Employing organisation


Organisation employing the chief investigator, investigators or other researchers. Employers remain liable for the work of their employees. The organisation employing the chief investigator normally holds the contract or grant agreement with the funder of the study. Organisations holding contracts with funders remain responsible for the management of the funds provided.


Funder


Organisation providing funding for a study (through contracts, grants or donations to an authorised member of the employing and/or care organisation). The main funder typically has a key role in scientific quality assurance. In any case, it remains responsible for securing value for money.


Investigator


Person responsible, individually or as leader of the researchers at a site, for the conduct of a study at that site. For clinical trials involving medicines, an investigator must be an authorised health professional.


Organisation providing care


Organisation responsible for providing health or social care to patients and/or service users and carers participating in a study. Health and social care organisations remain liable for the quality of care, and for their duty towards anyone who might be harmed.


Participant


Patient, service user, carer, relative of the deceased, professional carer, other employee, or member of the public, who consents to take part in a study. (In law, participants in clinical trials involving medicines are known as subjects.)


Principal investigator


The leader responsible for a team of individuals conducting a study at a site.


Researchers


Those conducting the study.


Research ethics committee


Committee established to provide participants, researchers, funders, sponsors, employers, care organisations and professionals with an independent opinion on the extent to which proposals for a study comply with recognised ethical standards. For clinical trials involving medicines, the ethics committee must be one recognised by the United Kingdom Ethics Committee Authority.


Responsible care professional


Doctor, nurse, social worker or other practitioner formally responsible for the care of participants while they are taking part in the study.


Sponsor


Individual, organisation or group taking on responsibility for securing the arrangements to initiate, manage and finance a study. (A group of individuals and/or organisations may take on sponsorship responsibilities and distribute them by agreement among the members of the group, provided that, collectively, they make arrangements to allocate all the responsibilities in this research governance framework that are relevant to the study.)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 24, 2017 | Posted by in NURSING | Comments Off on Research governance

Full access? Get Clinical Tree

Get Clinical Tree app for offline access